Application of patient-controlled analgesia with nalbuphine in cleft palate surgery in children

Application of patient-controlled analgesia with differernt doses of nalbuphine in cleft palate surgery in children

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027385

Enrollment

Unknown

Registered

2019-11-11

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cleft palate repair

Interventions

contral group:Normal saline

experimental group:nalbuphine

Eligibility

Sex/Gender

All

Age

No minimum to 2 Years

Inclusion criteria

Inclusion criteria: No special history and positive results were found in the patients who underwent selective cleft palate operation.

Exclusion criteria

Exclusion criteria: Serious liver and kidney dysfunction, congenital heart disease, severe upper respiratory tract infection and severe malnutrition were excluded.

Design outcomes

Primary

Measure	Time frame
Ramsay score;Restlessness score;	—

Countries

China

Contacts

Public ContactBaohua Gao

Xiamen Chang Gung Hospital Co., Ltd.

gaobh8636@126.com+86 15359885054

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026